Dr Reddy’s arm inks pact with US-based Olema Pharmaceuticals
SynopsisAurigene will also be eligible for up to USD 60 million in potential clinical development and regulatory milestones and up to USD 370 million in...
Continue ReadingSynopsisAurigene will also be eligible for up to USD 60 million in potential clinical development and regulatory milestones and up to USD 370 million in...
Continue ReadingSuccessful trials for RSV vaccine add much-needed lift to the UK drugmaker’s pipelineGlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older...
Continue ReadingEnsuring uninterrupted supply of medicines to patients and doctors in Sri Lanka is among Sun Pharma’s top priorities. The company has been exploring several alternatives...
Continue ReadingFDA cleared Abbott’s FreeStyle Libre 3, which is expected to be the most accurate and smallest continuous glucose monitoring sensor on the market.Just ahead of...
Continue Reading18 rectal cancer patients were given the same drug for six months and as a result of the treatment, cancer was completely obliterated in every...
Continue Reading“I come from one of the richest families in Orissa, we were brought up in a world of our own. We were taught to act...
Continue ReadingAccording to the companies, Abevmy follows the launch of their two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in...
Continue ReadingDrugmaker, Glenmark Pharma, has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with five observations after an inspection at...
Continue ReadingThe acquisition will strengthen Torrent’s positioning in gynaecology and urology therapyTorrent Pharmaceuticals Limited, announced acquisition of four brands in the therapeutic areas of gynaecology and...
Continue Reading